EU cracks down on blood pressure medicine made by Mylan

European Union authorities on Monday stepped in to effectively ban sales of blood pressure medicine valsartan made by an India-based unit of Mylan NV after some batches were found to contain a probable cancer-causing impurity, the latest in a global crackdown.

The European regulator said the unit’s compliance certificate had been suspended, effectively prohibiting the use of its valsartan in medicines in the region.

The affected batches are being recalled and tests conducted to determine the extent of the contamination, the European Medicines Agency said https://www.ema.europa.eu/en/news/valsartan-mylan-laboratories-india-can-no-longer-be-used-eu-medicines-due-ndea-impurity on Monday.

The batches were found to contain N-nitrosodiethylamine (NDEA), a probable carcinogen, and were made in Mylan’s Hyderabad facility in India, the EMA said.

Cancer-causing impurities have been linked to batches of valsartan over the past year, leading to a global recall.

The U.S. Food and Drug Administration last month halted imports of drug ingredients or medicines made with ingredients produced at a factory belonging to a Chinese bulk manufacturer of valsartan, Zhejiang Huahai Pharmaceuticals .

Huahai has recalled valsartan products made at its factory in China’s Chuannan province after N-nitrosodimethylamine (NDMA), another impurity linked to cancer, was found.

Mylan did not immediately respond to a request for comment.

(Reporting by Tamara Mathias in Bengaluru; Editing by Maju Samuel)

  • Related Posts

    • Pharma
    • July 9, 2025
    • 105 views
    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore. The…

    • Pharma
    • July 9, 2025
    • 111 views
    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    That half-empty bottle of painkillers or expired anxiety pills in your drawer could do more harm than good and Apex drug regulatory body, CDSCO, has said it’s best to flush…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    HC-ordered expert panel for weight loss drug may be set up by mid-July

    HC-ordered expert panel for weight loss drug may be set up by mid-July